Gritstone Oncology racks up $102 mln Series A
San Francisco Bay area-based Gritstone Oncology, a cancer immunotherapy company, has raised $102 million in Series A financing. The investors included Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital and Transformational Healthcare Opportunity.
20 October 2015•6 mins read
